Quetiapine Fumarate

CAS 111974-72-2 46 current records 13 historicalSmall Molecule

Who holds supplier records for Quetiapine Fumarate? 46 organisations hold a current record for Quetiapine Fumarate: an active US FDA Type II Drug Master File or a CEP. A further 13 organisations have only historical (inactive) DMF filings. 34 of them hold a valid EU Certificate of Suitability (35 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (30), China (5), Spain (3), Italy (2) and 3 other countries (3); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Quetiapine Fumarate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/quetiapine-fumarate

Reading the evidence

  • 46 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    30 of the 43 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 29 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (46)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Quetiapine Fumarate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Quetiapine Fumarate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (35)

Certificates of Suitability on the EDQM register for Quetiapine Fumarate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 53 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2022-280 - Rev 03
Quetiapine Fumarate, Micronised and non-micronised
Nov 2026Inspected May 2026
Italy
ALEMBIC PHARMACEUTICALS LIMITED VadodaraIN
CEP 2020-278 - Rev 02
Quetiapine Fumarate, Form-I
Oct 2026—
TAPI NL B.V. AmsterdamNL
CEP 2020-234 - Rev 04
Quetiapine Fumarate, ID 3871
Oct 2026—
NOSCH LABS PRIVATE LIMITED HyderabadIN
CEP 2018-160 - Rev 03
Quetiapine Fumarate, Unit-IV
Aug 2026—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
CEP 2018-017 - Rev 02
Quetiapine Fumarate
Aug 2026—
ALMON HEALTHCARE PRIVATE LIMITED AhmedabadIN
CEP 2024-537 - Rev 00
Quetiapine Fumarate
Jul 2026—
OLON S.P.A. RodanoIT
CEP 2024-275 - Rev 01
Quetiapine Fumarate, Process II
Jun 2026Inspected Mar 2025
Italy
AARTI PHARMALABS LIMITED Mulund (W), MumbaiIN
CEP 2019-291 - Rev 03
Quetiapine Fumarate
May 2026—
UNICHEM LABORATORIES LIMITED MumbaiIN
CEP 2025-581 - Rev 00
Quetiapine Fumarate, QTR Process
May 2026—
VASUDHA PHARMA CHEM LIMITED HyderabadIN
CEP 2019-035 - Rev 03
Quetiapine Fumarate
Mar 2026—
ZHEJIANG APELOA JIAYUAN PHARMACEUTICAL CO., LTD. DongyangCN
CEP 2025-013 - Rev 00
Quetiapine Fumarate
Mar 2026—
SYNTHIMED LABS PRIVATE LIMITED DerabassiIN
CEP 2015-178 - Rev 02
Quetiapine Fumarate
Feb 2026Inspected Aug 2026
Slovenia
ALKEM LABORATORIES LIMITED MumbaiIN
CEP 2025-036 - Rev 00
Quetiapine Fumarate
Jan 2026—
HIKAL LIMITED BengaluruIN
CEP 2024-272 - Rev 01
Quetiapine Fumarate, Process-B
Dec 2025Inspected Nov 2025
Switzerland
ZHEJIANG HISOAR CHUANNAN PHARMACEUTICAL CO., LTD. Taizhou CityCN
CEP 2015-218 - Rev 01
Quetiapine Fumarate
Dec 2025Inspected Jan 2024
Germany
HETERO LABS LIMITED HyderabadIN
CEP 2015-153 - Rev 04
Quetiapine Fumarate, Form-I
Nov 2025—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2014-224 - Rev 04
Quetiapine Fumarate
Sept 2025—
NIFTY LABS PRIVATE LIMITED HyderabadIN
CEP 2021-289 - Rev 04
Quetiapine Fumarate, Process II
Sept 2025—
JUBILANT BIOSYS LIMITED NanjangudIN
CEP 2014-108 - Rev 03
Quetiapine Fumarate
Sept 2025—
COHANCE LIFESCIENCES LIMITED MumbaiIN
CEP 2017-175 - Rev 02
Quetiapine Fumarate
Jul 2025—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2023-005 - Rev 02
Quetiapine Fumarate, Process-II
Jun 2025—
MEGA FINE PHARMA PRIVATE LIMITED MumbaiIN
CEP 2014-198 - Rev 02
Quetiapine Fumarate
May 2025—
IOL CHEMICALS AND PHARMACEUTICALS LTD LudhianaIN
CEP 2023-102 - Rev 00
Quetiapine Fumarate
Mar 2025—
Moehs Iberica S.L. RubiES
CEP 2018-277 - Rev 03
Quetiapine Fumarate, Standard and milled
Feb 2025—
IPCA LABORATORIES LIMITED MumbaiIN
CEP 2018-163 - Rev 02
Quetiapine Fumarate
Nov 2024—
LUPIN LIMITED MumbaiIN
CEP 2016-221 - Rev 01
Quetiapine Fumarate
Oct 2024—
DIVI'S LABORATORIES LIMITED HyderabadIN
CEP 2021-452 - Rev 00
Quetiapine Fumarate
May 2024—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2014-200 - Rev 01
Quetiapine Fumarate
Mar 2024—
MEDICHEM, S.A. Sant Joan DespíES
CEP 2014-081 - Rev 01
Quetiapine Fumarate
Dec 2023—
FERMION OY EspooFI
CEP 2015-170 - Rev 01
Quetiapine Fumarate
Oct 2023Inspected Feb 2026
Finland
INDOCO REMEDIES LIMITED MumbaiIN
R1-CEP 2014-279 - Rev 01
Quetiapine Fumarate
Oct 2022—
HIKAL LIMITED BangaloreIN
R1-CEP 2016-255 - Rev 00
Quetiapine Fumarate
Oct 2022—
EGIS Pharmaceuticals PLC BudapestHU
R1-CEP 2016-049 - Rev 00
Quetiapine Fumarate
Jul 2022—
Union Quimico Farmaceutica, S.A. (Uquifa S.A.) BarcelonaES
R1-CEP 2016-271 - Rev 00
Quetiapine Fumarate, Code 1378
Mar 2022—
ZHEJIANG SUPOR PHARMACEUTICALS CO., LTD. ShaoxingCN
R1-CEP 2015-024 - Rev 00
Quetiapine Fumarate
Feb 2021—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (13)

Organisations whose Type II DMFs for Quetiapine Fumarate are no longer active. These show a past filing, not current supply.

Show all 13 historical records
  • China · Inactive DMF 26689 · filed Dec 2012
  • SYNKEM SAS
    Inactive DMF 25951 · filed Mar 2012
  • RANBAXY LABORATORIES LTD
    Inactive DMF 25084 · filed Jun 2011
  • DISHMAN PHARMACEUTICALS AND CHEMICALS LTD
    Inactive DMF 24761 · filed Mar 2011
  • Spain · Inactive DMF 21826 · filed Jul 2008
  • India · Inactive DMF 21207 · filed Jan 2008
  • Italy · Inactive DMF 20981 · filed Oct 2007
  • Czechia · Inactive DMF 20854 · filed Sept 2007
  • SUZHOU NUMBER 4 PHARMACEUTICAL FACTORY
    Inactive DMF 20706 · filed Jul 2007
  • UNION QUIMICO FARMACEUTICA SA
    Inactive DMF 20311 · filed Feb 2007
  • JUBILANT ORGANOSYS LTD
    Inactive DMF 19836 · filed Sept 2006
  • Spain · Inactive DMF 19563 · filed Jun 2006
  • India · Inactive DMF 18797 · filed Sept 2005

Overview

Quetiapine Fumarate is an atypical antipsychotic used in the treatment of schizophrenia, bipolar disorder, and major depressive disorder. It acts by antagonizing multiple neurotransmitter receptors in the brain, exhibiting effects on serotonin and dopamine systems.

Chemical identity

IUPAC name
bis(2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol);(E)-but-2-enedioic acid
Canonical SMILES
C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C(=C/C(=O)O)\C(=O)O
InChIKey
ZTHJULTYCAQOIJ-WXXKFALUSA-N
Synonyms
Seroquel API, fk-947e, fk947e, ici 204,636, ici-204636, quetiapine (as fumarate), quetiapine hemifumarate, seroquel, utapine, zd-5077, zd5077, zm 204,636

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Atypical Antipsychotic

Therapeutic areas

PsychiatryNeurology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Quetiapine Fumarate?

46 organisations hold an active US FDA Type II Drug Master File or a CEP for Quetiapine Fumarate: Hetero Labs Limited (India), APITORIA PHARMA PRIVATE LTD (India), TAPI NL BV (Netherlands), Unichem Laboratories Ltd. (India), AARTI PHARMALABS LIMITED (India), Alembic Pharmaceuticals Limited (India), Alkem Laboratories Limited (India) and COHANCE LIFESCIENCES LTD (India), and 38 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Quetiapine Fumarate Drug Master Files are active?

Hetero Labs Limited (DMF 25770, 30627), APITORIA PHARMA PRIVATE LTD (DMF 37881, 19516), TAPI NL BV (DMF 18341, 37041), Unichem Laboratories Ltd. (DMF 22888, 35130), AARTI PHARMALABS LIMITED (DMF 21336), Alembic Pharmaceuticals Limited (DMF 23351), Alkem Laboratories Limited (DMF 40251) and COHANCE LIFESCIENCES LTD (DMF 32085) and 29 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Quetiapine Fumarate records mean?

13 organisations have only inactive Type II DMFs for Quetiapine Fumarate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Quetiapine Fumarate have a European Certificate of Suitability?

Yes. 34 organisations hold a valid CEP for Quetiapine Fumarate on the EDQM register, including ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou (CN), ALEMBIC PHARMACEUTICALS LIMITED Vadodara (IN), TAPI NL B.V. Amsterdam (NL), NOSCH LABS PRIVATE LIMITED Hyderabad (IN), MACLEODS PHARMACEUTICALS LIMITED Mumbai (IN) and ALMON HEALTHCARE PRIVATE LIMITED Ahmedabad (IN) and 29 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Quetiapine Fumarate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Quetiapine Fumarate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.